BSE Live
Apr 10, 16:01Prev. Close
25.04
Open Price
25.74
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Panjon (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -2.21 | -0.11 | 0.06 | 0.19 | 0.06 | |
| Diluted EPS (Rs.) | -2.21 | -0.11 | 0.06 | 0.19 | 0.06 | |
| Cash EPS (Rs.) | -2.13 | -0.06 | 0.14 | 0.41 | 0.29 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 10.34 | 15.71 | 13.86 | 13.80 | 13.60 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 10.34 | 15.71 | 13.86 | 13.80 | 13.60 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 12.57 | 12.45 | 17.92 | 15.13 | 10.01 | |
| PBDIT/Share (Rs.) | -1.96 | 0.10 | 0.15 | -0.71 | 0.32 | |
| PBIT/Share (Rs.) | -2.04 | 0.05 | 0.07 | -0.93 | 0.09 | |
| PBT/Share (Rs.) | -2.04 | 0.05 | 0.07 | -0.93 | 0.03 | |
| Net Profit/Share (Rs.) | -2.21 | -0.11 | 0.06 | 0.19 | 0.06 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -15.57 | 0.82 | 0.86 | -4.66 | 3.16 | |
| PBIT Margin (%) | -16.21 | 0.39 | 0.38 | -6.11 | 0.87 | |
| PBT Margin (%) | -16.21 | 0.39 | 0.38 | -6.11 | 0.33 | |
| Net Profit Margin (%) | -17.61 | -0.90 | 0.33 | 1.28 | 0.58 | |
| Return on Networth / Equity (%) | -21.41 | -0.71 | 0.42 | 1.40 | 0.43 | |
| Return on Capital Employed (%) | -18.13 | 0.28 | 0.31 | -5.69 | 0.56 | |
| Return on Assets (%) | -19.01 | -0.63 | 0.25 | 1.06 | 0.35 | |
| Total Debt/Equity (X) | 0.09 | 0.07 | 0.57 | 0.16 | 0.12 | |
| Asset Turnover Ratio (%) | 107.91 | 70.38 | 78.39 | 83.27 | 61.17 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 24.43 | 18.94 | 15.09 | 5.22 | 13.61 | |
| Quick Ratio (X) | 20.46 | 13.25 | 9.71 | 2.94 | 7.44 | |
| Inventory Turnover Ratio (X) | 7.80 | 3.38 | 3.39 | 3.41 | 2.31 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
04.03.2026
Panjon Standalone December 2025 Net Sales at Rs 14.14 crore, up 26.74% Y-o-Y
25.11.2025
Panjon Standalone September 2025 Net Sales at Rs 14.95 crore, up 342.44% Y-o-Y
14.11.2025
Panjon Standalone September 2025 Net Sales at Rs 14.95 crore, up 342.44% Y-o-Y
21.08.2025
Panjon Standalone June 2025 Net Sales at Rs 6.42 crore, up 206.63% Y-o-Y
04.03.2026
Panjon Standalone December 2025 Net Sales at Rs 14.14 crore, up 26.74% Y-o-Y
25.11.2025
Panjon Standalone September 2025 Net Sales at Rs 14.95 crore, up 342.44% Y-o-Y
14.11.2025
Panjon Standalone September 2025 Net Sales at Rs 14.95 crore, up 342.44% Y-o-Y
21.08.2025
Panjon Standalone June 2025 Net Sales at Rs 6.42 crore, up 206.63% Y-o-Y
10.04.2026
09.04.2026
08.04.2026
Indian CDMOs face tariff exposure via patented drug supply chains
08.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth